The long-term objectives of this proposal are to develop compliant, thoracic artificial lungs (cTALs) that can be used as a bridge to transplant for patients with end-stage respiratory disease. As a bridge to lung transplantation, a cTAL would allow for more patients to be transplanted and improve outcomes. Blood flow to the cTAL comes from the pulmonary artery (PA), driven by the right ventricle. Blood flow returns to the distal PA or branch of the PA (PA-PA attachment) or the left atrium (PA-LA attachment). These devices are designed to supply a patient's full gas transfer requirements with significantly less coagulation and inflammation than with extracorporeal membrane oxygenation (ECMO). Our group's previous work has led to devices that met these goals in large animals. However, this work also indicates that the fluid mechanical impedance of these devices can cause a significant reduction in cardiac output (CO) when attached in the PA- PA configuration. If not for this reduction in CO, PA-PA attachment would be the ideal means of attaching cTALs, as it allows the natural lung to maintain its normal filtration and metabolic functions. The cause of the reduction in CO is due, in large part, to excessive cTAL impedance. The studies in this proposal are aimed at designing a cTAL with very low impedance such that it can be used in any attachment configuration with little to no reduction in CO. This design should also allow for increases in CO with exercise. Five studies are proposed to meet this goal. (1) The relationship between pulmonary system impedance and CO will be determined using an intact heart, large animal model. The developed relationship will be used to set impedance benchmarks for the design of an improved cTAL that causes little to no reduction in CO during PA-PA attachment. (2) Fluid structure interaction (FSI) modeling will be used to design a cTAL that meets the impedance benchmarks. Preliminary FSI and in-vitro data indicates that cTAL impedance can be reduced to at least 33-50% of current thoracic artificial lungs. This should result in large improvements in CO during cTAL use. (3) The selected design will be tested in-vitro under pulsatile flow to confirm hemodynamic performance. (4) The cTAL will be tested in-vivo to determine short term (<8 hrs) gas exchange and hemodynamic performance in the PA-PA and PA-LA configurations at normal and elevated CO. Lastly, (5) the cTAL will be tested in-vivo over 14 days to assess device performance and animal physiology. All animal studies will utilize a model of pulmonary hypertension during chronic lung disease. The resulting device will be ready for pre- clinical testing.

Public Health Relevance

The goal of this project is to design and test compliant artificial lungs. These devices will give chronic lung disease patients more time to find a donor lung and improve their health before and after transplantation.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL089043-04
Application #
8197545
Study Section
Special Emphasis Panel (ZRG1-RES-B (03))
Program Officer
Harabin, Andrea L
Project Start
2009-01-01
Project End
2013-12-31
Budget Start
2012-01-01
Budget End
2013-12-31
Support Year
4
Fiscal Year
2012
Total Cost
$356,921
Indirect Cost
$109,421
Name
University of Michigan Ann Arbor
Department
Surgery
Type
Schools of Medicine
DUNS #
073133571
City
Ann Arbor
State
MI
Country
United States
Zip Code
48109
Scipione, Christopher N; Schewe, Rebecca E; Koch, Kelly L et al. (2013) Use of a low-resistance compliant thoracic artificial lung in the pulmonary artery to pulmonary artery configuration. J Thorac Cardiovasc Surg 145:1660-6
Amoako, Kagya A; Montoya, Patrick J; Major, Terry C et al. (2013) Fabrication and in vivo thrombogenicity testing of nitric oxide generating artificial lungs. J Biomed Mater Res A 101:3511-9
Schewe, Rebecca E; Khanafer, Khalil M; Orizondo, Ryan A et al. (2012) Thoracic artificial lung impedance studies using computational fluid dynamics and in vitro models. Ann Biomed Eng 40:628-36
Pohlmann, Joshua R; Akay, Begum; Camboni, Daniele et al. (2012) A low mortality model of chronic pulmonary hypertension in sheep. J Surg Res 175:44-8
Schewe, Rebecca E; Scipione, Christopher N; Koch, Kelly L et al. (2012) In-parallel attachment of a low-resistance compliant thoracic artificial lung under rest and simulated exercise. Ann Thorac Surg 94:1688-94
Khanafer, Khalil; Cook, Keith; Marafie, Alia (2012) THE ROLE OF POROUS MEDIA IN MODELING FLUID FLOW WITHIN HOLLOW FIBER MEMBRANES OF THE TOTAL ARTIFICIAL LUNG. J Porous Media 15:113-122
Akay, Begum; Foucher, Julie A; Camboni, Daniele et al. (2012) Hemodynamic design requirements for in-series thoracic artificial lung attachment in a model of pulmonary hypertension. ASAIO J 58:426-31
Schewe, Rebecca E; Khanafer, Khalil M; Arab, Aarthi et al. (2012) Design and in vitro assessment of an improved, low-resistance compliant thoracic artificial lung. ASAIO J 58:583-9
Lin, Yu-Chun; Khanafer, Khalil M; Bartlett, Robert H et al. (2011) An Investigation of Pulsatile Flow Past Two Cylinders as a Model of Blood Flow in an Artificial Lung. Int J Heat Mass Transf 54:3191-3200
Akay, Begum; Reoma, Junewai L; Camboni, Daniele et al. (2010) In-parallel artificial lung attachment at high flows in normal and pulmonary hypertension models. Ann Thorac Surg 90:259-65